RAMAN SPECTROSCOPIC STUDY ON PREDICTION OF TREATMENT RESPONSE IN CERVICAL CANCERS

S. RUBINA; M. S. VIDYASAGAR; C. MURALI KRISHNA

doi:10.1142/s1793545813500144

[1] J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, D. M. Parkin, GLOBOCAN, IARC CancerBase No. 10 (2008).

[2] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), Summary Report (2010).

[3] R. Sankaranarayanan, R. Swaminathan, "Lucas E. Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)," IARC Scientific Publications 162, ISBN 978-92-832-2162-3, Lyon, International Agency for Research on Cancer, (2011).

[4] K. Ohara, A. Oki, Y. O. Tanaka, K. Onishi, N. Fukumitsu, T. Hashimoto, T. Satoh, H. Tsunoda, M. Hata, S. Sugahara, K. Tokuuye, Y. Akine, H. Yoshikawa, "Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high and low-response tumor," Int. J. Radiat. Oncol. Biol. Phys. 64(4), 1179-1182 (2006).

[5] E. L. V. P. V. Meerten, H. Gelderblom, J. L. Bloem, "RECIST revised: Implications for the radiologist. A review article on the modified RECIST guideline," Eur. Radiol. 20, 1456-1467 (2010).

[6] J. F. Torres-Roca, C. W. Stevens, "Predicting response to clinical radiotherapy: Past, present, and future directions," Cancer Control. 15, 151-156 (2008).

[7] B. K. Jeong, D. H. Choi, S. J. Huh, W. Park, D. S. Bae, B. Kim, "The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix," Radiat. Oncol. J. 29(3), 191-198 (2011).

[8] V. M. Nagy, R. Buiga, I. Brie, N. Todor, O. Tudoran, C. Ordeanu, P. Virag, O. Tarata, M. Rus, O. Balacescu, "Expression of VEGF, VEGFR, EGF, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy," Rom. J. Morphol. Embryol. 52(1), 53-59 (2011).

[9] M. S. Vidyasagar, M. Kodal, P. P. Saxen, D. Upadhya, C. Murali Krishn, B. M. Vadhiraja, D. J. Fernandes, S. R. B. Sadashiva, "Predictive and prognostic significance of glutathione levels and DNA damage in cervix cancer patients undergoing radiotherapy," Int. J. Radiat. Oncol. Biol. Phys. 78(2), 1-7 (2010).

[10] D. W. Lee, Y. T. Kim, J. H. Kim, S. Kim, S. W. Kim, E. J. Nam, J. W. Kim, "Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy," J. Gynecol. Oncol. 21, 18-23 (2010).

[11] V. N. Harry, S. I. Semple, D. E. Parkin, F. J. Gilbert, "Use of new imaging techniques to predict tumour response to therapy," Lancet Oncol. 11, 92-102 (2010).

[12] D. J. Evers, B. H. W. Hendriks, G. W. Lucassen, T. J. M. Ruers, "Optical spectroscopy: Current advances and future applications in cancer diagnostics and therapy," Future Oncol. 8(3), 307-320 (2012).

[13] A.Mahadevan-Jansen, R. Richards-Kortum, "Raman spectroscopy for the detection of cancers and precancers," J. Biomed. Opt. 1, 31 (1996).

[14] A. Mahadevan-Jansen, M. F. Mitchell, N. Ramanujam, U. Utzinger, R. R. Kortum, "Development of a fiber optic probe to measure NIR Raman spectra of cervical tissue in vivo," Photochem. Photobiol. 68(3), 427-431 (1998).

[15] U. Utzinger, D. Heintzelman, A. Mahadevan- Jansen, A. Malpica, M. Follen, R. R. Kortum, "Near-infrared Raman spectroscopy for in vivo detection of cervical precancers," Appl. Spectrosc. 55(8), 955-959 (2001).

[16] E. M. Kanter, E. Vargis, S. Majumder, M. D. Keller, E. Woeste, G. G. Rao, A. Mahadevan-Jansen, "Application of Raman spectroscopy for cervical dysplasia diagnosis," J. Biophoton. 2(1-2), 1-10 (2009).

[17] E. M. Kanter, S. Majumder, G. J. Kanter, E. Woeste, A. Mahadevan-Jansen, "Effect of hormonal variation on Raman spectra for cervical disease detection," Amer. J. Obstet. Gynecol. 200(5), 1-13 (2009).

[18] J. Mo, W. Zheng, J. J. H. Low, J. Ng, A. Ilancheran, Z. Huang, "High wavenumber Raman spectroscopy for in vivo detection of cervical dysplasia," Anal. Chem. 81, 8908-8915 (2009).

[19] S. Duraipandian, W. Zheng, J. Ng, J. J. H. Low, A. Ilancheran, Z. Huang, "Simultaneous fingerprint and high-wavenumber confocal Raman spectroscopy enhances early detection of cervical precancer in vivo," Anal. Chem. 84(14), 5913-5919 (2012).

[20] S. Duraipandian, W. Zheng, J. Ng, J. J. H. Low, A. Ilancheran, Z. Huang, "Effect of hormonal variation on in vivo high wavenumber Raman spectra improves cervical precancer detection," Proc. SPIE 8214 Advanced Biomedical and Clinical Diagnostic Systems X, 82140A (2012).

[21] C. Murali Krishn, G. D. Socklingum, B. M. Vadhiraj, M. Kodal, Anuradh, L. Rao, L. Venteo, M. Pluot, D. J. Fernandes, M. S. Vidyasaga, V. B. Karth, M. Manfait, "Vibrational spectroscopy studies of formalin-fixed cervix tissues," Biopolymer 85, 1-8 (2006).

[22] M. S. Vidyasaga, M. Kodal, B. M. Vadhiraja, D. J. Fernandes, V. B. Kartha, C. Murali Krishn, "Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study," Biopolymer (2008).

[23] M. S. Vidyasagar, M. Kodal, B. M. Vadhiraja, D. J. Fernandes, V. B. Karth, C. Murali Krishn, "Raman spectroscopy of tissue collected at different fractions of radiation therapy: Response assessment to radiotherapy in cervix cancer," Proc. 49th Annual ASTRO Mettin, 2329 Int. J. Radiat. Oncol. 69(3) (2007).

[24] M. Kodal, B. M. Vadhiraja, K. Pralaha, M. S. Vidyasaga, D. J. Fernandes, V. B. Kartha, C. Murali Krishn, "Evaluation and validation of Raman spectroscopic diagnosis methodology of cervix cancers by blind studies," Proc. 49th Annual ASTRO Mettin, 2351 Int. J. Radiat. Oncol. 69(3) (2007).

[25] S. P. Singh, A. Deshmukh, P. Chaturvedi, C. Murali Krishna, "Raman spectroscopy in head and neck cancers: Toward oncological applications," J. Cancer Res. Ther. 8(6), 126-132 (2012).

[26] A. Nijssen, K. Maquelin, P. J. Caspers, T. C. B. Schut, M. H. A. Neumann, G. J. Puppels, "Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy," J. Biomed. Opt. 12, 034004-1-034004-7 (2007).

[27] S. Koljenovic, L. P. Choo-Smith, T. C. B. Schut, J. M. Kros, H. J. Berge, G. J. Puppels, "Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy," Lab. Invest. 82, 1265-1277 (2002).

[28] C. Gobinet, V. Vrabie, M. Manfait, O. Piot, "Preprocessing methods of Raman spectra for source extraction on biomedical samples: Application paraffin-embedded skin biopsies," IEEE Trans. Biomed. Engrg. 56(5), 1371-1342 (2009).

[29] A. D. Ghanate, S. Kothiwale, S. P. Singh, D. Bertrand, C. Murali Krishna, "Comparative evaluation of spectroscopic models using different multivariate statistical tools in a multicancer scenario," J. Biomed. Opt. 16(2), 1-9 (2011).

[30] P. Crow, B. Barrass, C. Kendall, M. Hart-Prieto, M. Wright, R. Persad, N. Stone, "The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines," British J. Cancer 92, 2166-2170 (2005).

[31] T. J. Harvey, E. Gazi, A. Henderson, R. D. Snook, N. W. Clarke, M. Brown, P. Gardner, "Factors influencing the discrimination and classification of prostrate cancer cell lines by FTIR microspectroscopy," Analyst 134(6), 1083-1091 (2009).

[32] A. Mahadevan-Jansen, M. F. Mitchell, N. Ramanujam, A. Malpica, S. Thomsen, U. Utzinger, R. R. Kortum, "Near-infrared Raman spectroscopy for in vitro detection of cervical precancers," Photochem. Photobiol. 68(1), 123-132 (1998).

[33] C. Murali Krishna, N. B. Prathima, R. Malini, B. M. Vadhiraja, R. A. Bhatt,D. J. Fernandes, P. Kushtagi, M. S. Vidyasagar, V. B. Kartha, "Raman spectroscopy studies for diagnosis of cancers in human uterine cervix," Vibr. Spectrosc. 41, 136-141 (2006).

[34] F. M. Lyng, E. O. Faolain, J. Conroy, A. D. Meade, P. Knief, B. Duffy, M. B. Hunter, J. M. Byrne, P. Kelehan, H. J. Byrne, "Vibrational spectroscopy for cervical cancer pathology, from biochemical analysis to diagnostic tool," Vibr. Spectrosc. 82, 121-129 (2007).